Propanc Biopharma’s CSO Predicts PRP Could Solve Problem That Impacts...
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleShionogi Provides Updates on Zatolmilast, an Investigational Drug for Fragile...
OSAKA, Japan Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced progress on the development program for...
View Articleベイジーン、アーロン・ローゼンバーグ氏を最高財務責任者に任命
カリフォルニア州、サンマテオ (ビジネスワイヤ) — グローバル・オンコロジー企業のベイジーン(NASDAQ:BGNE;HKEX:06160;SSE:688235)は、アーロン・ローゼンバーグ氏を7月22日付で最高財務責任者(CFO)に任命したことを発表しました。ローゼンバーグ氏はジュリア・ワンの後任となります。ワンは引継ぎのために8月までベイジーンに在籍し、退職後は外部の機会を追求します。...
View ArticleEuropean Medicines Agency Accepts Deciphera’s Marketing Authorization...
OSAKA, Japan & WALTHAM, Mass. Ono Pharmaceutical, Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) today announced that the European Medicines Agency (EMA) has accepted...
View ArticleGilead and the Elton John AIDS Foundation Announce Additional Five Years of...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) today announced a five-year extension of the RADIAN® partnership to help meet the needs of the most...
View Article2 Million Lives in Care – AIDS Healthcare Foundation Reaches a Historic...
LOS ANGELES AIDS Healthcare Foundation (AHF) proudly announces a monumental achievement in its mission to provide cutting-edge medicine and advocacy regardless of ability to pay – 2 million lives in...
View ArticleSamsara Vision Announces First SING IMT® (Smaller-Incision New-Generation...
FAR HILLS, N.J. Samsara Vision, a company focused on bringing vision and freedom back to patients with late-stage, age-related macular degeneration (AMD) through advanced visual prosthetic devices,...
View ArticleTriastek Announces Research Collaboration and Platform Technology License...
NANJING, China Triastek Inc. (“Triastek”), a global leader in 3D printing pharmaceuticals, today announced that it has entered into a research collaboration and platform technology license agreement...
View ArticleBCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s...
WASHINGTON Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also...
View Articleベイジーン、米国に生物製剤製造および臨床研究開発の旗艦施設を開設し、世界のより多くの患者に医薬品を届けるためのグローバルな拡大を継続
ニュージャージー州ホープウェル (ビジネスワイヤ) — がん領域専門のグローバル製薬企業であるベイジーン(NASDAQ: BGNE; HKEX: 06160; SSE:...
View ArticleFast Company Magazine Awards Xenco Medical with 2024 Innovation by Design...
SAN DIEGO Fast Company Magazine has awarded pioneering life sciences company Xenco Medical with its prestigious 2024 Innovation by Design Award for its groundbreaking TrabeculeX Continuum, the first...
View ArticleFIGS Announces Date of Second Quarter 2024 Earnings Release, Conference Call...
SANTA MONICA, Calif. FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its second...
View ArticleFujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research...
TOKYO & MALVERN, Pa. & GENT, Belgium H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G GFAP assay for the fully...
View ArticleFujirebio推出研究专用全自动Lumipulse®G GFAP检测试剂盒并进一步强化该公司的神经病学产品阵容
东京、宾夕法尼亚州马尔文、比利时根特 (美国商业资讯)– H.U. Group Holdings Inc.及其全资子公司Fujirebio今天宣布推出Lumipulse G GFAP检测试剂盒,用于该公司的全自动随机存取LUMIPULSE...
View ArticleDr. Reddy’s Q1FY25 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2024. The...
View ArticleGuardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening...
PALO ALTO, Calif. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test...
View ArticleDr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced that the...
View ArticleCarestream 荣获 Grupo Mídia 的牙科类杰出奖
ROCHESTER, N.Y. (美国商业资讯)– 我们非常荣幸地宣布,6 月 6 日,Carestream 凭借其牙片产品获得了著名的健康领先奖(牙科类)。该奖项被认为是行业内的最高荣誉,汇集了医疗保健生产链中的若干参与者,如医院、经营商、供应商等。评选方法结合了网站的公开投票、以及由权威的 Grupo Mídia 编辑委员会进行的最近 12 个月的市场调查。...
View Articleケアストリームのデンタル・フィルムが有名な賞を獲得
ニューヨーク州ロチェスター (ビジネスワイヤ) — ケアストリームは、ブラジルの名声ある国際マルチメディア企業であるグルポ・ミディアから歯科部門の「ヘルス・リーダー・アワード」を授与されたことをお知らせいたします。...
View ArticleGuardant Health的Shield™血液检查被FDA批准为初级筛查选项,为医疗保险报销扫清了障碍,开创了结直肠癌筛查的新纪元
加州帕洛阿尔托 (美国商业资讯)– 领先的精准肿瘤学公司Guardant Health, Inc. (Nasdaq:...
View Article